Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1984 Nov;53(3):575–582.

C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.

H Kitamura, M Matsumoto, K Nagaki
PMCID: PMC1454908  PMID: 6237987

Abstract

C3-independent immune haemolysis was studied using EAC14oxy2 cells and purified C5, C6, C7, C8 and C9. We have found that EAC14oxy2 cells were lysed by C5-C9 and that haemolysis occurs, even after pretreatment of the cells and the C5-C9 preparation with anti-C3. This indicates that EAC14oxy2 can be lysed by C5-C9 without any participation of C3. In contrast, EAC1 and EAC14 cells are not lysed by C5-C9, suggesting that our C5-C9 preparation lacks activated complement components, such as C3bBb, C5b6 or C(56)a. Based on our study of the haemolysis of EAC14oxy2, we have determined that: (i) EAC14oxy2 cells are lysed by a preparation of C5, C6, C7, C8 and C9, but no lysis occurs when any one of these complement is absent, (ii) for significant haemolysis of EAC14oxy2, a higher concentration of C5 is necessary as compared to the C5 requirement when haemolysis occurs in the presence of C3, (iii) the degree of haemolysis is linearly related to the concentration of C5 and does not reach a plateau, despite the addition of as much as 3,200 U of C5, and (iv) the degree of haemolysis is linearly related to the concentration of cell bound C42. These observations suggest that, in the absence of C3, the C3 convertase C42 can activate C5 directly, resulting in the formation of the membrane attack complex, C5b-9.

Full text

PDF
575

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bolotin C., Morris S., Tack B., Prahl J. Purification and structural analysis of the fourth component of human complement. Biochemistry. 1977 May 3;16(9):2008–2015. doi: 10.1021/bi00628a039. [DOI] [PubMed] [Google Scholar]
  2. Hammer C. H., Hänsch G., Gresham H. D., Shin M. L. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a. J Immunol. 1983 Aug;131(2):892–898. [PubMed] [Google Scholar]
  3. Kitamura H., Inai S. Molecular analysis of the reaction of C9 with EAC1-8: reaction of C9 with EAC1-8. J Immunol. 1974 Dec;113(6):1992–2003. [PubMed] [Google Scholar]
  4. Kitamura H., Nagaki K. Inhibitory effect of sugars on the spontaneous lysis of EAC1-8. Mol Immunol. 1981 Nov;18(11):985–990. doi: 10.1016/0161-5890(81)90116-4. [DOI] [PubMed] [Google Scholar]
  5. Kitamura H., Nishimukai H., Sano Y., Nagaki K. Study on C3-like factor in the serum of a C3-deficient subject. Immunology. 1984 Feb;51(2):239–245. [PMC free article] [PubMed] [Google Scholar]
  6. Mayer M. M. The complement system. Sci Am. 1973 Nov;229(5):54–66. doi: 10.1038/scientificamerican1173-54. [DOI] [PubMed] [Google Scholar]
  7. Nagaki K., Iida K., Okubo M., Inai S. Reaction mechanisms of beta1H globulin. Int Arch Allergy Appl Immunol. 1978;57(3):221–232. doi: 10.1159/000232106. [DOI] [PubMed] [Google Scholar]
  8. Nelson R. A., Jr, Jensen J., Gigli I., Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry. 1966 Mar;3(2):111–135. doi: 10.1016/0019-2791(66)90292-8. [DOI] [PubMed] [Google Scholar]
  9. Podack E. R., Kolb W. P., Müller-Eberhard H. J. Purification of the sixth and seventh component of human complement without loss of hemolytic activity. J Immunol. 1976 Feb;116(2):263–269. [PubMed] [Google Scholar]
  10. Polley M. J., Müller-Eberhard H. J. Enharncement of the hemolytic activity of the second component of human complement by oxidation. J Exp Med. 1967 Dec 1;126(6):1013–1025. doi: 10.1084/jem.126.6.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pussell B. A., Bourke E., Nayef M., Morris S., Peters D. K. Complement deficiency and nephritis. A report of a family. Lancet. 1980 Mar 29;1(8170):675–677. [PubMed] [Google Scholar]
  12. Sano Y., Nishimukai H., Kitamura H., Nagaki K., Inai S., Hamasaki Y., Maruyama I., Igata A. Hereditary deficiency of the third component of complement in two sisters with systemic lupus erythematosus-like symptoms. Arthritis Rheum. 1981 Oct;24(10):1255–1260. doi: 10.1002/art.1780241005. [DOI] [PubMed] [Google Scholar]
  13. Shin H. S., Pickering R. J., Mayer M. M. The fifth component of the guinea pig complement system. 3. Dissociation and transfer of C5b, and the probable site of C5b fixation. J Immunol. 1971 Feb;106(2):480–493. [PubMed] [Google Scholar]
  14. Tack B. D., Prahl J. W. Third component of human complement: purification from plasma and physicochemical characterization. Biochemistry. 1976 Oct 5;15(20):4513–4521. doi: 10.1021/bi00665a028. [DOI] [PubMed] [Google Scholar]
  15. Tack B. F., Morris S. C., Prahl J. W. Fifth component of human complement: purification from plasma and polypeptide chain structure. Biochemistry. 1979 Apr 17;18(8):1490–1497. doi: 10.1021/bi00575a016. [DOI] [PubMed] [Google Scholar]
  16. Takahashi M., Takahashi S., Hirose S. Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions. Prog Allergy. 1980;27:134–166. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES